| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872dd7cd609eb2a937dcfd303d521798 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate |
2016-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01e01e79d8cd628321c26844a361567d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3120784d3be1e175acbb44bd31d8043 |
| publicationDate |
2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017067881-A1 |
| titleOfInvention |
Pyrazine compounds for use in the treatment of parasitic protozoal infections |
| abstract |
The present invention relates to compounds of Formula (I) having pharmacological activity, processes for its preparation, pharmaceutical compositions and their use in the treatment of certain parasitic certain parasiticprotozoalinfections such as malaria, in particular infection by Plasmodium falciparum. Formula (I), wherein R is methyl or fluoro. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019145360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111936488-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111936488-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023094305-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7057427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021510726-A |
| priorityDate |
2015-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |